[Seoul, 13th Reuters]–The Korea Disease Control and Prevention Agency (KDCA) has announced that it plans to start treatment with Pfizer’s new oral coronavirus infection drug, Paxlobido, on the 14th.
At least 21,000 Paxrobids arrived on the 13th. It is said that it will be distributed to about 280 pharmacies and 90 medical facilities.
“Given the extremely high infectivity of the Omicron strain, a senior KDCA official said that (the use of Paxrovid) plays an important role in reducing the number of patients at risk of aggravation.”
Paxrovid is planned to be administered to more than 1000 people per day for people at high risk of aggravation, people aged 65 and over, and people with high priority such as immunodeficiency.
An additional 10,000 Paxrobids are expected to arrive later this month.
.
